摘要
目的:探讨乌司他丁对重型颅脑损伤(SCCI)对患者脑氧代谢、炎性因子及肾功能的影响。方法:将98例SCCI患者随机分为对照组和观察组,每组患者49例。对照组患者给予常规对症支持治疗,观察组患者在此基础上给予乌司他丁滴注治疗。比较两组治疗前及治疗第3 d、7 d的脑氧代谢(SjvO_2、CaO_2、A-vDO_2和CERO_2)、炎性因子(TNF-α、IL-6和IL-10)及肾功能(BUN和Cr)的变化。结果:治疗前,两组患者的SjvO_2、CaO_2、A-vDO_2、CERO_2、TNF-α、IL-6、IL-10、BUN和Cr水平比较差异均无统计学意义(P>0.05);治疗3 d、7 d,观察组患者的SjvO_2、CaO_2和IL-10水平均显著高于对照组,A-vDO_2、CERO_2、TNF-α、IL-6、BUN和Cr水平均显著低于对照组,差异显著具统计学意义(P<0.05)。结论:乌司他丁治疗SCCI可有效改善患者的脑氧代谢、肾功能,减轻炎症反应。
Objective: To investigate the influence of ulinastatin on the cerebral oxygen metabolism inflammatory factors and renal function of patients with severe craniocerebral injury. Methods: 98 cases of SCCI patients were randomly divided into the control group (n=49) and the observation group (n=49). The control group was given routine symptomatic treatment, while the observation group was treated with ulinastatin on the basis of control group. The cerebral oxygen metabolism (SjvO2, CaO2, A-vDO2 and CERO2), inflam- matory factors (TNF-α, IL-6 and IL-10) and renal function (BUN and Cr) were compared between the two groups before and at 3 d, 7 d after treatment. Results: No significant difference of SjvO2, CaO2, A-vDO2, CERO2, TNF-α, IL-6, IL-10, BUN and Cr levels between the two groups before treatment (P〉0.05). At 3d, 7d after treatment, the levels of SjvO2, CaO2 and IL-10 in the observation group were signif- icantly higher than those in the control group, the levels of A-vDO2, CERO2, TNF-α, IL-6, BUN and Cr were significantly lower than those in the control group(P〈0.05). Conclusion: Ulinastatin could effectively improve the cerebral oxygen metabolism and renal function, relieve the inflammatory response in the treatment of SCCI.
出处
《现代生物医学进展》
CAS
2017年第29期5694-5697,共4页
Progress in Modern Biomedicine
基金
新疆维吾尔自治区攻关项目(201528332986)
关键词
重型颅脑损伤
乌司他丁
脑氧代谢
炎性因子
肾功能
Severe craniocerebral injury
Ulinastatin
Cerebral oxygen metabolism
Inflammatory factor
Renal function